| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Medical Officer
2 companies
Roberts Eiry is a Director at FOLD with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 5 sells.
Estimated insider holdings value: $6.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 23, 2020 | NBIX Neurocrine Biosciences Inc | Chief Medical Officer | Sale+OE | 5,000 | $130.00 | $650,000.00 | -34.7% | |
| Apr 24, 2020 | NBIX Neurocrine Biosciences Inc | Chief Medical Officer | Sell | 1,934 | $99.47 | $192,376.33 | -17.0% | |
| Feb 7, 2020 | NBIX Neurocrine Biosciences Inc | Chief Medical Officer | Sell | 1,623 | $103.31 | $167,675.38 | -17.9% | |
| Jan 8, 2020 | NBIX Neurocrine Biosciences Inc | Chief Medical Officer | Sell | 2,632 | $111.11 | $292,444.94 | -30.5% | |
| Jan 8, 2019 | NBIX Neurocrine Biosciences Inc | Chief Medical Officer | Sell | 1,857 | $84.09 | $156,158.66 | -37.1% |